ACET

Adicet Bio, Inc.

Healthcare · Biotechnology

$104.18 sample

-0.47 (-0.45%) 1D

Market cap

$105.9B

Price as of

2026-10-23

Latest filing

8-K · 2026-09-25

Alerts

8

Price$104.18 +1.33% 3M daily closessample

109.52100.54

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider buy: Chief Executive Officer
Oct 15INSInsider buy: Director
Oct 07INSInsider buy: Chief Financial Officer
Oct 02INSInsider buy: Chief Executive Officer
Sep 25SECDEF 14A filed
Sep 18INSInsider buy: EVP, Operations
Sep 10INSInsider sell: Director
Sep 01INSInsider buy: Chief Executive Officer

Sign up to see the real ACET record →

Company facts

SEC EDGAR registration

Name: Adicet Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +52sample, -100 to +100
Reporting currency: USD

Who is positioning in ACET

sample

Insiders: 8 insider transactions over 90 days, net selling, $128.9M
Congress: 4 members traded over 90 days
Institutions · 13F: 10 funds hold $2.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.6B +14.2% y/y

Q4 2024Q3 2026

Inventory$2.8B +8.7% y/y

Q4 2024Q3 2026

Accounts receivable$2.0B +10.1% y/y

Q4 2024Q3 2026

Total debt$5.5B +16.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $17.7B -11.4% 3M
Sample peer B: $48.9B -13.5% 3M
Sample peer C: $71.2B +6.2% 3M
Sample peer D: $35.9B +6.8% 3M
Sample peer E: $67.5B +7.1% 3M